Home
Home

antisense

Isis Pharmaceuticals Making Antisense

Isis Pharmaceuticals Making Antisense
Seeking Alpha

Xenon licenses antisense drug SEN701 from Isis Pharmaceuticals

Xenon licenses antisense drug SEN701 from Isis Pharmaceuticals
Yahoo/Fly on the Wall

Roche to use Isis's technology to develop brain disorder drug

Roche to use Isis's technology to develop brain disorder drug
Reuters

Isis Publishes Encouraging Data

Isis Publishes Encouraging Data
Yahoo/Zacks

Isis Pharmaceuticals Launches Trial, Hits Milestone

Isis Pharmaceuticals Launches Trial, Hits Milestone
Motley Fool

Biogen Idec and Isis Pharmaceuticals Announce Collaboration For Antisense Programs To Treat Neurological Disorders

Biogen Idec and Isis Pharmaceuticals Announce Collaboration For Antisense Programs To Treat Neurological Disorders
Yahoo

Isis To Receive $1.25 Million Payment As Pfizer Continues Development Of EXC 001

Isis To Receive $1.25 Million Payment As Pfizer Continues Development Of EXC 001
Yahoo

Biogen Idec and Isis Pharmaceuticals Announce Global Collaboration for Antisense Program Targeting Myotonic Dystrophy

Biogen Idec and Isis Pharmaceuticals Announce Global Collaboration for Antisense Program Targeting Myotonic Dystrophy
Yahoo

Keeping An Eye On Isis

Keeping An Eye On Isis
Seeking Alpha

News

Isis Pharma receives US$ 10 mn from OncoGenex' license of OGX-O11 to Teva
Pharmabiz
»